Dermatological manifestations during COVID‐19 and histological picture: Description of two clinical cases
Autor: | Alessandra Scarabello, Silvia Mosti, Silvia Rosati, Concetta Castilletti, Fabrizio Palmieri, Eleonora Lalle, Gina Gualano, Virginia Di Bari, Laura Falasca, Roberta Nardacci, Raffaella Libertone, Maria Musso, Paola Mencarini, Franca Del Nonno, Daniele Colombo |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Concise Communications rash Dermatology Virus Lymphocytic Infiltrate 030207 dermatology & venereal diseases 03 medical and health sciences Basal (phylogenetics) COVID-19 Testing 0302 clinical medicine Immune system COVID‐19 Humans inflammation markers Medicine skin biopsy medicine.diagnostic_test SARS-CoV-2 business.industry Concise Communication COVID-19 General Medicine Exanthema medicine.disease SARS‐CoV‐2 infection Rash Pneumonia Erythema 030220 oncology & carcinogenesis Skin biopsy Histopathology medicine.symptom business |
Zdroj: | The Journal of Dermatology |
ISSN: | 1346-8138 0385-2407 |
DOI: | 10.1111/1346-8138.15714 |
Popis: | It is not yet entirely clear what is the relevance of skin symptoms and what clinical implications are related to their appearance in COVID‐19 patients. We describe two cases of COVID‐19‐associated pneumonia, which presented skin manifestations in advanced stage of illness, when nasopharyngeal swabs became negative for SARS‐CoV‐2. The first case presented erythematous, maculopapular lesions; the second developed petechial, vesicular and blood‐encrusted lesions on the limbs. Histopathology documented perivascular lymphocytic infiltrates, with prevalent CD4+ T‐cells in both patients. The research of SARS‐CoV‐2 in tissues with real time RT‐PCR was negative. Basal keratinocytes displayed C4d deposits in one case, who developed laboratory signs indicative of a procoagulative condition at the same time as the skin rash. Skin manifestations during SARS‐CoV‐2 infection seem to be clinically relevant and further studies are necessary to assess if they are linked to systemic complications, lack of viral clearance or cascades of immune responses induced by the virus, even in patients affected by mild pneumonia. |
Databáze: | OpenAIRE |
Externí odkaz: |